Ocular Therapeutix, Inc. Adds $6 Million to C Round

Xconomy -- Ocular Therapeutix, a Bedford, MA-based developer of therapies for the eye, has brought in an additional $6 million for its Series C round, which now totals $21 million, company co-founder and CEO Amar Sawhney confirmed via e-mail today.